Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
BI 907828 for previously untreated advanced dedifferentiated liposarcoma	BI 907828	Advanced dedifferentiated liposarcoma	Sarcoma	2023	View \| Download
Bifikafusp alfa-onfekafusp alfa neoadjuvant therapy for treating resectable stage IIIB and IIIC melanoma	Daromun	Melanoma	Skin Cancer	2023	View \| Download
BIIB092 for progressive supranuclear palsy	Gosuranemab (BIIB092; BMS-986168; IPN007)	Progressive supranuclear palsy (PSP)	Neurology	2019	View \| Download
Bimatoprost slow-release for ocular hypertension or open-angle glaucoma	Bimatoprost SR Occular	Ocular hypertension	Ophthalmology	2021	View \| Download
Bimekizumab for active psoriatic arthritis	Bimekizumab (UCB4940)	Psoriatic arthritis	Dermatology , Rheumatology	2021	View \| Download
Bimekizumab for ankylosing spondylitis	Bimekizumab (UCB4940)	Ankylosing spondylitis	Musculoskeletal System	2021	View \| Download
Bimekizumab for Hidradenitis Suppurativa	Bimekizumab (UCB4940)	Hidradenitis suppurativa (HS)	Dermatology	2022	View \| Download
Bimekizumab for moderate to severe chronic plaque psoriasis	Bimekizumab (UCB4940)	Plaque psoriasis	Dermatology	2019	View \| Download
Bimekizumab for non-radiographic axial spondyloarthritis	Bimekizumab (UCB4940)	Axial spondyloarthritis	Rheumatology	2021	View \| Download
Bintrafusp alfa for advanced, unresectable cervical cancer	Bintrafusp alfa (M7824; GSK4045154)	Cervical cancer	Female Reproductive Cancer	2021	View \| Download